AstraZeneca Confirms It Is Mulling Strategic Options For Astra Tech

AstraZeneca PLC confirmed it is considering the spin-off of Astra Tech business, Reuters reported. AstraZeneca hired JP Morgan Chase to help with the review of options for the dental implants and medical devices maker. A source familiar with the situation told Reuters earlier this week that the Anglo-Swedish drugmaker was looking to sell the Swedish-based business for $2 billion. Reuters reported Astra Tech could be of interest to privately held companies and private equity firms according to industry analysts.

ManagersNorth AmericaUSBriefs